Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Parkinson’s Disease and Zoledronic Acid (TOPAZ) Study

Nurse assisting patient in hospital


AGE: 60 years or older
TYPE: Interventional Treatment
CONDITION: Parkinson’s Disease, parkinsonsism

Learn More About This Research Study

This is a research study being conducted at University Hospitals. For more information, please contact Steven Gunzler at 216-844-8685 (option 3) or complete the online form below.

Study Purpose

The purpose of the TOPAZ study is to determine whether zoledronic acid, an approved bone strengthening medication for osteoporosis, can prevent fractures and decrease the risk of dying in people with Parkinson’s disease and other parkinsonism.  The information learned in this study will help doctors understand whether they should treat their patients with PD with zoledronic acid.

Who Can Participate

Participants 60 years of age and older with Parksinson’s disease or another form of parkinsonism who have not had a hip fracture may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

I'm not a robot

Study ID

  • STUDY20210436